Financials Medikit Co.,Ltd.

Equities

7749

JP3921060004

Medical Equipment, Supplies & Distribution

Market Closed - Japan Exchange 02:00:00 2024-05-02 am EDT 5-day change 1st Jan Change
2,766 JPY -0.54% Intraday chart for Medikit Co.,Ltd. -1.18% -4.65%

Valuation

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Capitalization 1 50,612 46,627 51,798 54,785 39,117 41,010
Enterprise Value (EV) 1 26,390 21,082 24,966 27,294 10,999 13,418
P/E ratio 20.5 x 18.1 x 17.9 x 20.7 x 13.1 x 14.3 x
Yield 1.26% 1.64% 1.64% 1.53% 2.58% 2.87%
Capitalization / Revenue 2.9 x 2.52 x 2.6 x 2.84 x 1.94 x 1.9 x
EV / Revenue 1.51 x 1.14 x 1.26 x 1.41 x 0.55 x 0.62 x
EV / EBITDA 5.68 x 4.19 x 4.43 x 5.37 x 1.93 x 2.47 x
EV / FCF 12 x 11.3 x 12.2 x 15.5 x 4.97 x 4.53 x
FCF Yield 8.34% 8.87% 8.17% 6.44% 20.1% 22.1%
Price to Book 1.33 x 1.16 x 1.23 x 1.26 x 0.85 x 0.87 x
Nbr of stocks (in thousands) 16,955 16,955 16,955 16,805 16,803 16,787
Reference price 2 2,985 2,750 3,055 3,260 2,328 2,443
Announcement Date 6/29/18 6/28/19 6/29/20 6/30/21 6/30/22 6/29/23
1JPY in Million2JPY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net sales 1 17,445 18,501 19,893 19,312 20,130 21,607
EBITDA 1 4,647 5,034 5,642 5,083 5,688 5,437
EBIT 1 3,633 3,856 4,324 3,775 4,419 4,114
Operating Margin 20.83% 20.84% 21.74% 19.55% 21.95% 19.04%
Earnings before Tax (EBT) 1 3,717 3,892 4,333 3,928 4,472 4,290
Net income 1 2,465 2,576 2,887 2,659 2,993 2,864
Net margin 14.13% 13.92% 14.51% 13.77% 14.87% 13.25%
EPS 2 145.4 151.9 170.3 157.4 178.1 170.6
Free Cash Flow 1 2,201 1,869 2,040 1,757 2,212 2,963
FCF margin 12.62% 10.1% 10.26% 9.1% 10.99% 13.71%
FCF Conversion (EBITDA) 47.36% 37.13% 36.16% 34.57% 38.9% 54.49%
FCF Conversion (Net income) 89.28% 72.56% 70.67% 66.08% 73.92% 103.45%
Dividend per Share 2 37.50 45.00 50.00 50.00 60.00 70.00
Announcement Date 6/29/18 6/28/19 6/29/20 6/30/21 6/30/22 6/29/23
1JPY in Million2JPY
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: March 2020 S1 2021 S1 2022 S1 2022 Q3 2023 Q1 2023 S1 2023 Q3 2024 Q1 2024 S1 2024 Q3
Net sales 1 10,007 9,623 10,008 5,526 5,294 10,562 5,886 5,549 10,845 6,015
EBITDA - - - - - - - - - -
EBIT 1 2,261 1,891 2,202 1,286 1,081 2,024 1,295 1,230 2,276 1,423
Operating Margin 22.59% 19.65% 22% 23.27% 20.42% 19.16% 22% 22.17% 20.99% 23.66%
Earnings before Tax (EBT) 1 2,279 1,943 2,245 1,242 1,102 2,045 1,461 1,264 2,397 1,419
Net income 1 1,258 1,065 1,400 761 537 1,196 932 564 1,320 811
Net margin 12.57% 11.07% 13.99% 13.77% 10.14% 11.32% 15.83% 10.16% 12.17% 13.48%
EPS 2 74.25 62.85 83.33 45.32 32.04 71.29 55.52 33.62 78.64 48.31
Dividend per Share - - - - - 30.00 - - 35.00 -
Announcement Date 11/13/19 11/12/20 11/11/21 2/10/22 8/10/22 11/11/22 2/10/23 8/10/23 11/10/23 2/9/24
1JPY in Million2JPY
Estimates

Balance Sheet Analysis

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - -
Net Cash position 1 24,222 25,545 26,832 27,491 28,118 27,592
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 2,201 1,869 2,040 1,757 2,213 2,963
ROE (net income / shareholders' equity) 6.62% 6.59% 7.02% 6.2% 6.7% 6.16%
ROA (Net income/ Total Assets) 5.25% 5.32% 5.67% 4.77% 5.47% 4.93%
Assets 1 46,970 48,399 50,905 55,755 54,714 58,057
Book Value Per Share 2 2,250 2,362 2,487 2,597 2,728 2,817
Cash Flow per Share 2 1,429 1,507 1,583 1,636 1,676 1,644
Capex 1 1,047 1,706 1,445 1,536 1,779 983
Capex / Sales 6% 9.22% 7.26% 7.95% 8.84% 4.55%
Announcement Date 6/29/18 6/28/19 6/29/20 6/30/21 6/30/22 6/29/23
1JPY in Million2JPY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Equities
  3. 7749 Stock
  4. Financials Medikit Co.,Ltd.